CMS is proposing actions to address the health equity gap, ensure consumers have the information they need to make fully informed decisions regarding their health
Join Us for Our Upcoming Webinar: August 5, 2021 • 12:00 PM – 1:00 PM During this webinar, the featured presenter will provide an overview
The West Virginia Rural Health Association knows how it important it is to make sure our brightest and best health graduates and professionals have an
Vaccine uptake among direct service workers (DSWs) is particularly important for personal health and safety and to the many individuals that DSWs support, due to the high contact, personal nature of home care.
Indigenous Conference Services is pleased to announce the high-calibre of our keynote speakers for the upcoming 2021 Closing the Gap Indigenous Health Conference and 2021 National Indigenous Chronic Diseases Conference at the Seaworld Resort Gold Coast on November 22-24, 2021.
Equahealth Program – Free Medical Care None of the Nonsense
The FDA approved Epclusa (sofosbuvir and velpatasvir) oral pellets (200/50 mg and 150/37.5 mg) for the treatment of genotypes 1, 2, 3, 4, 5, or 6, chronic hepatitis C virus (HCV) infection in pediatric patients who are at least 3 years of age.
FDA approved Mavyret (glecaprevir and pibrentasvir) oral pellets (100mg/40mg) for the treatment of pediatric patients 3 to less than 12 years of age weighing less than 45 kg with chronic hepatitis C virus genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis.